Medical Market Report

Global Post-Operative Nausea And Vomiting (Ponv) Market By Type (Serotonin Antagonists, Steroids, Dopamine Antagonists, Nk-1 Receptor Antagonists, Others, And Non-Pharmacologic Treatment), By Application (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies And Drug Stores, And ), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2020-2029

  • 134648
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Post-operative Nausea and Vomiting (PONV) Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global post-operative nausea and vomiting (ponv) market is segmented on the basis of Type, Application, and geography.
    The global Post-operative Nausea and Vomiting (PONV) market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Post-operative Nausea and Vomiting (PONV) Market Scope:

    By type, the market is segmented into Serotonin Antagonists, Steroids, Dopamine Antagonists, NK-1 Receptor Antagonists, Others, and Non-pharmacologic Treatment. By Application, the market is divided into Hospital Pharmacies, Online Pharmacies, Retail Pharmacies and Drug Stores, and .
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Acacia Pharma, Roche AG, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai Corporation, Merck, and GlaxoSmithKline.

    Key Market Segments

    Type

    Serotonin Antagonists

    Steroids

    Dopamine Antagonists

    NK-1 Receptor Antagonists

    Others

    Non-pharmacologic Treatment

    Application

    Hospital Pharmacies

    Online Pharmacies

    Retail Pharmacies and Drug Stores

    Key Market Players included in the report:

    Acacia Pharma

    Roche AG

    Novartis

    Ani Pharmaceuticals

    Camurus

    Sanofi

    Helsinn Holding

    Eisai Corporation

    Merck

    GlaxoSmithKline

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Post-operative Nausea and Vomiting (PONV) Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Post-operative Nausea and Vomiting (PONV) Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Post-operative Nausea and Vomiting (PONV) Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Post-operative Nausea and Vomiting (PONV) Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Post-operative Nausea and Vomiting (PONV) Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Post-operative Nausea and Vomiting (PONV) Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Post-operative Nausea and Vomiting (PONV) sub-markets, depending on key regions (various vital states).
    To analyze Post-operative Nausea and Vomiting (PONV) Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Post-operative Nausea and Vomiting (PONV) Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Post-operative Nausea and Vomiting (PONV) Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Post-operative Nausea and Vomiting (PONV) Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Post-operative Nausea and Vomiting (PONV) Market Overview
    

    3.1. Post-operative Nausea and Vomiting (PONV) Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Manufacturer Intensity Map4. Global Post-operative Nausea and Vomiting (PONV) Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Post-operative Nausea and Vomiting (PONV) Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Serotonin Antagonists
    

      4.4. Steroids
    

      4.5. Dopamine Antagonists
    

      4.6. NK-1 Receptor Antagonists
    

      4.7. Others
    

      4.8. Non-pharmacologic Treatment5. Global Post-operative Nausea and Vomiting (PONV) Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Post-operative Nausea and Vomiting (PONV) Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospital Pharmacies
    

      5.4. Online Pharmacies
    

      5.5. Retail Pharmacies and Drug Stores
    

      5.6.6. Global Post-operative Nausea and Vomiting (PONV) Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Post-operative Nausea and Vomiting (PONV) Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Post-operative Nausea and Vomiting (PONV) Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Post-operative Nausea and Vomiting (PONV) Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia
    

      6.4. Latin America
    

        6.4.1. Latin America Post-operative Nausea and Vomiting (PONV) Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Post-operative Nausea and Vomiting (PONV) Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Post-operative Nausea and Vomiting (PONV) Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Acacia Pharma
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Roche AG
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Novartis
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Ani Pharmaceuticals
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Camurus
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Sanofi
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Helsinn Holding
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Eisai Corporation
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Merck
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. GlaxoSmithKline
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.